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Introduction
CGH techniques allow us to detect small duplications that
occur in humans with phenotypic manifestations and demon-
strate the importance of these duplications in the etiology
of neurodevelopmental impairment. As in the case of other
X-linked disorders, X-inactivation plays a major role in the
clinical expression of such X chromosomal imbalances with
usually milder symptoms in females than in males. Most
male patients carrying Xp duplication have mental retarda-
tion (X-linked mental retardation) and variable facial dys-
morphic features (Gimelli et al. 2002; Lugtenberg et al.
2006). Females with Xp duplications are usually protected
from genetic imbalance by the inactivation of their abnormal
X chromosome. Thus, preferential inactivation of the abnor-
mal X chromosome in females leads to a normal phenotype,
and it has been observed in the majority of these females
(Matsuo et al. 1999). In this study, we present a case with the
smallest duplication of Xp described to date, associated with
development delay, psychiatric manifestations and random X
inactivation in a human female. CGH array showed a 6-Mb
duplication, extending from Xp22.11 to Xp21.2. The molec-
ular characterization of such a small duplication might help
us to understand genotype–phenotype correlations in patients
with partial duplication of Xp.
Materials and methods
Case report
The proband was born at term to healthy and nonconsan-
guineous parents, from an uneventful pregnancy. At birth her
∗For correspondence. E-mail: piccionemaria@libero.it.
weight was 3.1 kg, the gestational age was unknown. The
mother referred two previous abortions within 24th gesta-
tional weeks. At 2 years of age, the patient suffered from
respiratory insufﬁciency and epiglottitis. Electroencephalo-
gram (EEG) examination at 2 years was normal. Motor mile-
stones were reached normally, but she had reduced cognitive
capacity, language disorder and physical hyperactivity since
infancy. When she was 7 years old, echocardiogram showed
mitral valve insufﬁciency. Evaluated when she was 10 years
old, her weight was 25.3 kg (10th percentile), her height
was 132.2 cm (25th percentile), her head circumference was
51.8 cm (25th percentile). Her 11- and 6-year-old brothers
were clinically normal. Ligament hyperlaxity, hypertelorism,
ﬂat nasal bridge, micrognatia, large and posteriorly rotated
ears were also observed (ﬁgure 1). Neurological examina-
tion showed mild mental retardation, hyperactivity, language
disorder and cognitive deﬁcits. EEG examination was nor-
mal. Abdominal ultrasound did not show abnormalities. Psy-
chological counselling was carried out and, although not
diagnosed as psychotic, she showed aggressive behaviour
problems and disorganization of thought process (prepsy-
chotic phase). She started therapy with levomepromazine
with good response to medication.
Fluorescent in situ hybridization
Single copy DNA probe of chromosome Xp, cloned in BAC,
was obtained from Resources for Human Molecular Cyto-
genetics (http://www.biologia.uniba.it/rmc/). FISH proce-
dure was performed as described by Cremer and Lichter
(1992). Slides were counterstained with 4′,6-diamidino-2-
phenylindole (DAPI) (200 ng/mL) and analysed by ﬂuores-
cence microscope Olympus BX70 equipped with a cooled
CCD Video Camera Image Point, Photometrics (Olympus,
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Figure 1. Front view and proﬁle of the patient: hypertelorism, ﬂat
nasal bridge, micrognatia, large and posteriorly rotated ears.
Center Valley, USA). Image analysis was carried out with
CytoVision software version 3.93.2 (Applied Imaging/PSI,
Santa Clara, USA).
CGH array
DNAs of proband and control were extracted with Pure-
gene DNA Isolation kit (Qiagen, Milan, Italy) according
to the manufacturer’s instructions. CGH-array analysis was
performed using a Human Genome CGH Microarray kit 4 ×
44 K (Agilent Technologies, Santa Clara, USA) with a reso-
lution of 200 kb according to the manufacturer’s instructions.
Array slides were analysed with a Agilent G2505B scanner.
Image analysis was carried out with Feature Extraction 9.5.1
(Agilent) and results visualized with CGH Analytics 3.4.40
(Agilent).
Analysis by microsatellites
To reveal the parental origin of de novo chromosome dupli-
cation Xp21.2, we carried out a gene dosage analysis by
microsatellite polymorphic markers on genomic DNA of the
patient and his parents. Four STRs (DXS8027, DXS7102,
DXS8065 and DXS9896) located inside the duplicated
region were chosen from UCSC database (http://genome.
ucsc.edu/cgi-bin/hgGateway). Primers sequences and PCR
conditions are available on request. For each marker, 1 mL
of PCR product was mixed with 20 μL of formamide and
1 μL of Genescan 350 ROX size standard (Applied Biosys-
tems, Foster City, USA). The mixture was denatured at 90◦C
Figure 2. A–B, X-inactivation proﬁle of the patient. A, electropherogram of PCR with primers for the methylated alleles.
B, Electropherogram of PCR with primers for the unmethylated alleles. C, The RP11–399D20 (Xp21.3) BAC probe shows
signals on the short arm of both X chromosomes. D, Genomewide array analysis of the proband showed a 6-Mb duplication
at Xp [dup(X)(p22.11p21.2)], ranging from 23,604 to 29,661 Mb.
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for 2 min. Capillary electrophoresis was performed using
POP7 gel and ABI PRISM 3130 Genetic Analyser (Applied
Biosystems). Fragment sizes and peak areas were deter-
mined by the GeneMapper software version 3.7. The analy-
sis of gene dosage was conducted according to the method
described by Di Bella et al. (2006).
X-inactivation analysis
The peripheral blood X-inactivation pattern in proposita was
determined at the human androgen receptor (HUMARA)
locus using a methylation-speciﬁc PCR (M-PCR) method
(Kubota et al. 1999). The PCR products and the geno-
typing marker Genescan-500 ROX size standard (Applied
Biosystems) were separated on an ABI 3130 automated
DNA sequencer and analysed with the GeneMapper analy-
sis software (Applied Biosystems) for peak position and area
intensity calculations.
Results
Genomewide array analysis of the proband showed a
6-Mb duplication at Xp (dup(X)(p22.11p21.2)), ranging
from 23,604 Mb to 29,661 Mb (ﬁgure 2D). This duplication
harboured known 23 genes (ﬁgure 2D). The RP11–399D20
(Xp21.3) BAC probe showed signals only on the short arm
of both X chromosomes, thus excluding a chromosomal
insertion (ﬁgure 2C).
FISH analysis on the proband and her parents con-
ﬁrmed the rearrangement (ﬁgure 2C), showing that it was
de novo and that the duplication was of paternal origin.
The X-inactivation analysis showed a random (50 : 50)
X-inactivation pattern in proposita (ﬁgure 2, A–B).
Discussion
We report on a girl with a small partial de novo duplica-
tion of Xp associated with abnormal phenotype. The nor-
mal and the duplicated X chromosomes in the patient we
described were randomly inactivated. Duplications involv-
ing the short arm of X chromosome are described in males
associated with mental retardation and facial dysmorphic fea-
tures. Case reports presenting duplication of Xp in females
are rare because females carrying Xp duplication are usually
protected by the inactivation of the chromosome which
contains the duplication. The negative effects of X dupli-
cation are related to the size of the functional imbalance
(Kolomietz et al. 2005). The present patient showed a small
duplication detected with CGH-array, the smallest described
to date, associated with mild dysmorphic features, mild men-
tal retardation, cognitive deﬁcits, language disorder and psy-
chiatric problems. The duplication we report on harbours 23
known genes and, since there is no gross functional imbal-
ance, we can speculate that the neurological impairments are
probably caused by a dosage effect of one or more genes
located within the duplicated region. X-linked MR is
believed to be caused by alterations in molecular pathways
that are important for cognitive functions and crucial for
neuronal morphogenesis. The duplicated segment harbours
two genes whose loss-of-function mutations have been asso-
ciated with X linked mental retardation: IL1RAPL1(MRX-
linked 21/34) and ARX (Chiurazzi et al. 2008). Till date, no
duplication of the entire genes ARX and IL1RAPL1 has been
considered to be responsible for neurodevelopmental impair-
ments. ARX gene belongs to the family of Aristaless-related
paired-class homeobox genes. Bienvenu et al. (2002) specu-
lated that ARX may act to regulate neuroepithelial cell prolif-
eration and the timing of neuronal differentiation and that the
mutation of the gene could affect the development of cogni-
tive function. Mutation of ARX gene is involved in X-linked
mental retardation (Strømme et al. 2002), in isolated agene-
sis of the corpus callosum in females (Kato et al. 2004), and
in learning difﬁculties in females without skewed X inacti-
vation (Poirier et al. 2006). Recently, it has been shown that
ARX is a transcription factor that participates in the develop-
ment of GABAergic and cholinergic neurons in the forebrain
(Kitamura et al. 2009). Missense, nonsense mutations and
deletion/insertions of ARX have been reported, associated
with mental retardation and developmental delay (Nawara
et al. 2008; Poirier et al. 2006; Troester et al. 2007). Malfor-
mation phenotypes are usually associated with protein trun-
cation mutations and missense mutations in the homeobox;
nonmalformation phenotypes, including X-linked infantile
spasm are associated with missense mutations outside the
homeobox and expansion of the polyA tracts (Ruggieri
et al. 2010). The 24-bp duplication (c.428_452dup) is the
most frequent pathogenic variation in ARX, associated with
intellectual disability (Demos et al. 2009).
IL1RAPL1 gene encodes for a member of the interleukin
1 receptor family protein and it is expressed at a high level
in post-natal brain structures involved in the hippocampal
memory system, which suggests a specialized role in the
physiological processes underlying memory and learning
abilities. Carrié et al. (1999) demonstrated the importance
of interleukin signalling pathways in cognitive functions by
studying the effects of disruption in the expression of genes
located within the Xp22.1-21.3 region. The authors found
that deletions and a nonsense mutation in this gene were
responsible for cognitive impairment in patients carrying the
disruption. IL1RAPL1 has been shown to interact with the
neuronal calcium sensor-1 protein (NCS-1), a protein widely
expressed in neurons, and to regulate N-type Ca2 channel
and neurite elongation (Gambino et al. 2007). Mutations
in the calcium-related IL1RAPL1 gene are also associated
with autism in both females and males (Piton et al. 2008).
Females with a loss-of-function mutation in IL1RAPL1 were
found to exhibit a spectrum of phenotypes ranging from no
obvious impairment to autism with or without mild men-
tal retardation. To date, no cases of IL1RAPL1 duplication
have been associated with cognitive and learning difﬁcul-
ties in males and females. Thorson et al. (2010) presented
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a female patient with moderate expressive language delay
caused by an interstitial duplication of Xp21-p22. The dupli-
cated region harbours several genes involved in X-linked
mental retardation (CDKL5, NHS and ARX) and the duplica-
tion is responsible for the interruption of the upstream por-
tion of the IL1RAPL1 gene, causing the inactivation of the
partially duplicated allele. It has been shown that inactivation
of IL1RAPL1 gene can result in cognitive delays (Nawara
et al. 2008), but, according to the ﬁndings of our case report,
we can speculate that both increased or decreased expression
of dosage sensitive genes can disrupt normal function and
development of CNS.
The phenotype of our patient is mild compared to previous
reported cases, where the duplicated segments were longer.
Some of the dysmorphic features of our case report over-
lap with clinical signs described in literature: hypertelorism
(Telvi et al. 1996; Matsuo et al. 1999), ﬂat nasal bridge
(Thorson et al. 2010), micrognatia (Gimelli et al. 2002), large
and posterior rotated ears (Matsuo et al. 1999). However,
the more frequent ﬁndings of microcephaly, hypotonia and
skeletal anomalies (Matsuo et al. 1999; Telvi et al. 1996;
Thorson et al. 2010) were not found in our case; this is proba-
bly due to the size of the duplicated segment which harbours
only 23 known genes, which are probably responsible for few
dysmorphic signs. The comparison with previously reported
patients is difﬁcult because only a few phenotypically abnor-
mal cases of small X chromosome duplication detected by
CGH-Array have been described so far. Most cases reported
with duplication of Xp carried large genomic imbalance and
molecular characterization has not always been performed. It
is not clear which of the genes involved in the duplication are
relevant to the phenotype and to the neurological disorders of
our patient. Two of the 23 genes involved have been associ-
ated with XLMR and we can suppose that the overexpression
of such genes could lead to the language impairments and to
the psychiatric disorders that our patient presents. It is possi-
ble that ARX duplication is responsible for the developmen-
tal impairments of our patient, or that the IL1RAPL1/NSC-1
interaction can be affected either by lack of expression or
by IL1RAPL1 functional disomy. We cannot exclude that
gene disruption at duplication breakpoints, or position effects
may have caused the phenotypical features. Descriptions of
additional patients with small Xp duplications are needed to
better correlate genotype and phenotype.
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